Development of Patient Derived Xenografts (PDXs) and Analysis of Tyrosine Kinase Receptor Expression in Patients With Squamous Cell Head and Neck Cancer (HNSCC) to Study Resistance Mechanisms Induced by Standard Therapy

NCT07471009 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Tumors of the Head and Neck (HNSCC)

Sponsor

IRCCS Azienda Ospedaliero-Universitaria di Bologna